GlassScriptPhysician profile
Thana Tarsha
NPI 1063432375
$1,073.15
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.45 · 2021: $83.31 · 2022: $369 · 2023: $281 · 2024: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $310.86 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medtronic, INC. | $132.29 | 2023 | Truclear |
| Exact Sciences Corporation | $112.85 | 2023-2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $112.72 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $62.84 | 2023-2024 | Veozah |
| Intuitive Surgical, INC. | $54.45 | 2021 | |
| Shield Therapeutics INC | $39.09 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $36.80 | 2024 | Exparel |
| Vertex Pharmaceuticals Incorporated | $30.75 | 2024 | |
| Channel Medsystems, INC. | $28.86 | 2021 | |
| Myovant Sciences INC. | $28.09 | 2022 | |
| Convatec INC. | $25.57 | 2022 | |
| Abbvie INC. | $24.45 | 2020 | |
| Avion Pharmaceuticals | $24.32 | 2022 | |
| Exeltis, USA INC. | $21.23 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $14.54 | 2024 | Summit Doppler |
| Minerva Surgical, INC | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thana Tarsha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.